CL2017000058A1 - Composición para uso en la prevención y tratamiento de rinitis alérgica. - Google Patents

Composición para uso en la prevención y tratamiento de rinitis alérgica.

Info

Publication number
CL2017000058A1
CL2017000058A1 CL2017000058A CL2017000058A CL2017000058A1 CL 2017000058 A1 CL2017000058 A1 CL 2017000058A1 CL 2017000058 A CL2017000058 A CL 2017000058A CL 2017000058 A CL2017000058 A CL 2017000058A CL 2017000058 A1 CL2017000058 A1 CL 2017000058A1
Authority
CL
Chile
Prior art keywords
hydrogenated
oil
prevention
treatment
composition
Prior art date
Application number
CL2017000058A
Other languages
English (en)
Inventor
Giorgio Panin
Jürgen Lamprecht
Original Assignee
Bio Lo Ga Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51589387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017000058(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Lo Ga Srl filed Critical Bio Lo Ga Srl
Publication of CL2017000058A1 publication Critical patent/CL2017000058A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)

Abstract

<p>COMPOSICIÓN PARA APLICACIÓN TÓPICA, PARA USO EN LA PREVENCIÓN Y TRATAMIENTO DE RINITIS ALÉRGICA, QUE CONSISTE EN UN ÉSTER DE ALFA-TOCOFEROL SELECCIONADO DEL GRUPO QUE CONSISTE EN ACETATO, N-PROPIONATO O LINOLEATO DE ALFA-TOCOFERILO, Y UN VEHÍCULO OLEOSO SELECCIONADO DEL GRUPO QUE CONSISTE EN POLIISOBUTENO HIDROGENADO, POLIDECENO HIDROGENADO, Y MEZCLAS DE POLIISOBUTENO HIDROGENADO Y/O POLIDECENO HIDROGENADO CON POLIOLEFINAS HIDROGENADAS, EN PARTICULAR POLIOLEFINAS C 6-C 14 HIDROGENADAS, TRIGLICÉRIDO CAPRÍLICO/CÁPRICO, ACEITE OLUS, ACEITE DE ADANSONIA DIGITATA, ACEITE DE SEMILLA DE ADANSONIA DIGITATA, CAPRILATO/CAPRATO DE COCO, ESCUALANO DE OLIVA, ESCUALENO DE OLIVA, ACEITE DE SEMILLA DE GIRASOL (HELIANTUS ANNUS), CAPRILATO DE COCO, ISONONANOATO DE ISONONILO, CICLOPENTASILOXANO, Y MEZCLAS DE LOS MISMOS.</p>
CL2017000058A 2014-07-22 2017-01-10 Composición para uso en la prevención y tratamiento de rinitis alérgica. CL2017000058A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20141332 2014-07-22

Publications (1)

Publication Number Publication Date
CL2017000058A1 true CL2017000058A1 (es) 2017-08-11

Family

ID=51589387

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000058A CL2017000058A1 (es) 2014-07-22 2017-01-10 Composición para uso en la prevención y tratamiento de rinitis alérgica.

Country Status (26)

Country Link
US (1) US20170165226A1 (es)
EP (1) EP3171873B1 (es)
CN (1) CN106659709A (es)
AR (1) AR101274A1 (es)
AU (1) AU2015294663B2 (es)
BR (1) BR112017001116A8 (es)
CA (1) CA2955664C (es)
CL (1) CL2017000058A1 (es)
CO (1) CO2017000550A2 (es)
CY (1) CY1122823T1 (es)
DE (1) DE202014106007U1 (es)
DK (1) DK3171873T3 (es)
EA (1) EA201692486A1 (es)
ES (1) ES2779525T3 (es)
GE (1) GEP20186830B (es)
HR (1) HRP20200380T1 (es)
HU (1) HUE049588T2 (es)
LT (1) LT3171873T (es)
MX (1) MX369991B (es)
PE (1) PE20170437A1 (es)
PL (1) PL3171873T3 (es)
PT (1) PT3171873T (es)
RS (1) RS60103B1 (es)
SI (1) SI3171873T1 (es)
SM (1) SMT202000194T1 (es)
WO (1) WO2016012110A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US4269835A (en) * 1979-12-13 1981-05-26 Whittle Barry J Nasal composition for relieving nasal distress
US20100055152A1 (en) * 2008-08-26 2010-03-04 Trutek Corporation Antihistamine and antihistamine-like nasal application, products, and method
DE4327089A1 (de) * 1993-08-12 1995-02-16 Roshdy Ismail Mittel zur Behandlung von allergischen Erkrankungen der Atemwege
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
ITMI981586A1 (it) * 1998-07-10 2000-01-10 Giorgio Panin Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
JP2003128552A (ja) * 2001-08-16 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
WO2004045556A2 (en) 2002-11-20 2004-06-03 Board Of Regents, The University Of Texas System Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens
JP2008266255A (ja) * 2007-04-24 2008-11-06 Project M:Kk アレルギー性疾患を予防および／または治療するための組成物
US20100076072A1 (en) 2008-07-25 2010-03-25 Northwestern University Compositions and methods of vitamin e administration
IT1393056B1 (it) * 2008-09-22 2012-04-11 Bio Lo Ga Srl Uso di vitamina e o suoi derivati per il controllo di artropodi
ITMI20090480A1 (it) * 2009-03-27 2010-09-28 Bio Lo Ga Srl Supporto tessile imbevuto di una composizione detergente/idratante
US10561720B2 (en) * 2011-06-24 2020-02-18 EpitoGenesis, Inc. Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators

Also Published As

Publication number Publication date
CY1122823T1 (el) 2021-05-05
CA2955664A1 (en) 2016-01-28
US20170165226A1 (en) 2017-06-15
EA201692486A1 (ru) 2017-07-31
DE202014106007U1 (de) 2015-07-23
SI3171873T1 (sl) 2020-07-31
CO2017000550A2 (es) 2017-03-31
AR101274A1 (es) 2016-12-07
PL3171873T3 (pl) 2020-07-13
CA2955664C (en) 2022-09-06
RS60103B1 (sr) 2020-05-29
MX2017000906A (es) 2017-05-12
BR112017001116A2 (pt) 2018-01-23
BR112017001116A8 (pt) 2022-07-05
AU2015294663B2 (en) 2019-11-21
DK3171873T3 (da) 2020-03-16
HUE049588T2 (hu) 2020-10-28
EP3171873A1 (en) 2017-05-31
WO2016012110A1 (en) 2016-01-28
EP3171873B1 (en) 2019-12-25
SMT202000194T1 (it) 2020-05-08
AU2015294663A1 (en) 2017-01-19
MX369991B (es) 2019-11-27
HRP20200380T1 (hr) 2020-08-07
CN106659709A (zh) 2017-05-10
GEP20186830B (en) 2018-02-26
ES2779525T3 (es) 2020-08-18
PE20170437A1 (es) 2017-04-22
LT3171873T (lt) 2020-04-10
PT3171873T (pt) 2020-02-25

Similar Documents

Publication Publication Date Title
CL2017000240A1 (es) Compuestos activos hacia bromodominios
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2017000902A1 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
CO2018005369A2 (es) Inhibidores triazol de acc y usos de los mismos
CL2018000078A1 (es) Procedimientos y composiciones para el diagnóstico y para el tratamiento de adrenoleucodistrofia.
CL2018000108A1 (es) Moléculas de anticuerpo que se unen a cd22
MX2020011104A (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
CR20150436A (es) Nuevos octahidro-pirrolo[3,4-c]-pirrol y -piridina-fenilo
CL2018000596A1 (es) Nuevos compuestos bicíclicos como inhibidores de la atx
MX2015012437A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
CL2017001046A1 (es) Inhibidoes del bromodominio
SV2016005316A (es) Compuestos y composiciones para inducir condrogénesis
EA201690753A1 (ru) Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств
MX2017017119A (es) Formulacion de alta concentracion.
AR102973A1 (es) Uso del compuesto 3,5-dihidroxi-4-isopropil-trans-estilbeno para la preparación de una composición farmacéutica, dicho compuesto y composición farmacéutica que lo comprende
CR20170076A (es) Derivados de pirimidima sustituidos con heterociclilo opcionalmente condensados útiles para el tratamiento de enfermedades inflamatorias, metabólicas, oncológicas y autoinmunitarias
AR101391A1 (es) Sistema de dos componentes para formulaciones cosméticas
MX386732B (es) Composición farmacéutica de corticosteroide soluble.
UY36292A (es) Compuestos de tetrahidroquinolina para su uso como inhibidores de bromodominios
MX2019008845A (es) Metodos y sistemas para mejorar la estabilidad de la formulacion prevapor de un dispositivo de vapeo electronico.
BR112019000371A2 (pt) composições líquidas para dispositivos de remoção de pelos que compreendem ésteres de poliol insaturados metatetizados
AR109910A1 (es) Reducción de los olores del betún y crmb
AU2015267160A8 (en) Methods and compositions for preventing ischemia reperfusion injury in organs
MX2017003469A (es) Inhibidores macrociclicos de cinasa rip2.
EA201790391A1 (ru) Композиции для ингибирования воспаления у субъекта с повреждением спинного мозга и способы их применения